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        Schwann cells develop in contact with and dependent on axons 
for signals that promote their genesis and subsequent differen-
tiation (  Jessen and Mirsky, 2005  ). In mature nerves, Schwann 
cells adopt one of two distinct fates: a nonmyelinating pheno-
type, in which multiple small-diameter axons are separately en-
closed within pockets of the Schwann cell (forming a Remak 
bundle), or a myelinating phenotype, in which they acquire a 
one/one association with and subsequently myelinate larger 
axons that express the promyelinating signal neuregulin 1 (  Fig. 1  ; 
  Nave and Salzer, 2006  ). Myelinating Schwann cells remain 
remarkably plastic throughout life. Thus, during Wallerian 
degeneration, axon transection initiates rapid Schwann cell de-
differentiation (i.e., down-regulation of myelin protein expression 
and up-regulation of nonmyelin markers) and proliferation 
(  Scherer and Salzer, 2001  ). These reprogrammed cordons of 
Schwann  cells,  termed   “ bands  of  B ü ngner, ”   provide  a  cellular 
substrate for nerve regeneration and subsequent remyelination. 
The events that underlie these changes in Schwann cell differen-
tiation have been largely obscure. In the current issue, Parkinson 
et al. (see p. 625) provide important insights into the mecha-
nisms by which injury promotes Schwann cell dedifferentiation. 
They show that the transcription factor c-Jun is up-regulated 
upon injury and antagonizes Krox-20, an important promyelin-
ating transcription factor, to promote a switch in the Schwann 
cell phenotype. 
Schwann cells are remarkably plastic cells that can both 
form and stably maintain myelin sheaths around axons 
and also rapidly dedifferentiate upon injury. New ﬁ  nd-
ings (Parkinson, D.B., A. Bhaskaran, P. Arthur-Farraj, L.A. 
Noon, A. Woodhoo, A.C. Lloyd, M.L. Feltri, L. Wrabetz, 
A. Behrens, R. Mirsky, and K.R. Jessen. 2008.   J. Cell Biol  . 
181:625  –  637) indicate that the transition between these 
distinct states of differentiation is directed by the transcrip-
tion factor Krox-20, which promotes and maintains mye-
lination, and c-Jun, which antagonizes it. Cross-inhibition 
of these transcription factors serves to switch Schwann 
cells between the myelinated and dedifferentiated pheno-
types, respectively.
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  Previous work on the regulation of the Schwann cell lin-
eage focused on elucidating the transcriptional cascade that pro-
motes myelination (  Jessen and Mirsky, 2005  ). Among these are 
factors that promote glial/Schwann cell specifi  cation and initial 
differentiation (e.g., Sox10 and NF    B) and those that promote 
Schwann cell differentiation to the promyelinating stage (i.e., 
Oct-6/SCIP and Brn2;   Fig. 1  ). The latter transcription factors, 
together with Sox10 (  Ghislain and Charnay, 2006  ), are required 
for the expression of Krox-20 (Egr2), which is essential for 
Schwann cell myelination. Recently, conditional inactivation of 
Krox-20 in the adult was shown to result in demyelination, in-
dicating that Krox-20 is also required to maintain the myelin 
sheath long after it has formed (  Decker et al., 2006  ). 
    Parkinson et al. (2008)   have now examined the role of c-Jun, 
a basic leucine zipper transcription factor and an important 
component of the AP-1 complex, in Schwann cell myelination. 
In previous studies, they reported that c-Jun is expressed by and 
promotes Schwann cell proliferation before myelination and that 
c-Jun  ’  s expression is then down-regulated at the onset of mye-
lination by Krox-20 (  Parkinson et al., 2004  ). In the current study, 
they demonstrate that c-Jun can potently inhibit myelination. 
Thus, forced expression of c-Jun inhibits myelin gene expression 
in cultured Schwann cells in response to promyelinating factors 
and also blocks myelination in neuron  –  Schwann cell cocultures. 
Loss of c-Jun by conditional inactivation of a fl  oxed allele 
enhanced myelin gene expression in cultured Schwann cells. 
These results suggest that c-Jun expression may regulate the 
onset of myelination during development, although its precise 
role during development remains to be determined. 
  It is of note that c-Jun is rapidly up-regulated in Schwann 
cells after injury. Explanting Schwann cells from nerves into 
culture (which removes them from contact with axons), treating 
myelinating cocultures with high doses of a growth factor to 
induce demyelination, or transecting nerves to initiate Wallerian 
degeneration all up-regulate c-Jun expression. This up-regulation 
appears to play an important role in promoting dedifferentiation. 
Conditional inactivation of c-Jun markedly delayed Schwann 
cell dedifferentiation under the aforementioned conditions, 
including, strikingly, during Wallerian degeneration of neonatal 
nerves. In the latter case, myelin sheaths remained intact even 
several days after axon transection. These fi  ndings indicate c-Jun 
activation has an important involvement in promoting dediffer-
entiation of Schwann cells after injury. Although dedifferentia-
tion and myelin sheath breakdown were signifi  cantly delayed, 
they still occurred, suggesting that other pathways may be involved 
(see subsequent paragraphs). 
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Each of these kinase pathways has been implicated in regulating 
Schwann cell differentiation. The Ras  –  MAPK pathway, like the 
JNK pathway, is a negative regulator of Schwann cell differ-
entiation and myelination (  Harrisingh et al., 2004  ;   Ogata et al., 
2004  ). In contrast, p38 kinase (  Haines et al., 2008  ), as well as 
phosphatidylinositol 3-kinase (  Maurel and Salzer, 2000  ), is pro-
myelinating. These fi  ndings suggest that a dynamic balance be-
tween promyelination and dedifferentiation signaling pathways 
operates during development and injury. This balance between pro-
myelination and dedifferentiation may be refl  ected in the dynamic 
switch between Krox-20 versus c-Jun and Sox-2, respectively. 
  Finally, these studies have important implications for the 
adaptive changes in Schwann cell differentiation that occur during 
development and after injury but likely in pathological settings 
as well. Many demyelinating neuropathies are characterized by 
Schwann cell dedifferentiation and proliferation (  Feldman et al., 
2008  ), and an emerging literature suggests that aberrant MAPK 
signaling may be involved (  Cavaletti et al., 2007  ). As such, these 
pathways, including the JNK signaling pathway highlighted by 
the studies of   Parkinson et al. (2008)  , may be attractive candi-
dates for targeted therapeutic intervention. 
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